However, treatment with losartan or resveratrol improved cognitive function in rats with Ang-II-induced early AD by abolishing ROS generation and reducing activity of the Aβ–caspase 3–Akt–GSK-3β-Tau pathway activity by negatively NOX2 levels. Here, CYBB is linked to Alzheimer disease.